NuScale Power (SMR) Earnings Analysis
NuScale Power (SMR) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it missed with EPS -0.14 USD vs -0.11 USD est (-27.3%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -3.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SMR next report earnings?
No confirmed upcoming earnings date is currently scheduled for SMR. This page updates as the calendar is published.
SMR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.14 USD | -0.11 USD | -27.3% | Miss |
| 2026-02-26 | -0.8 USD | -0.1 USD | -700% | Miss |
| 2025-11-06 | -1.85 USD | -0.13962 USD | -1225% | Miss |
| 2025-08-07 | -0.13 USD | -0.12 USD | -8.3% | Miss |
| 2025-05-12 | -0.11 USD | -0.13171 USD | +16.5% | Beat |
| 2025-03-03 | 0.6 USD | -0.11 USD | +645.5% | Beat |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
SMR valuation and analyst view
| Trailing P/E | -3.60 |
|---|---|
| Trailing EPS | -2.35632 USD |
| Price / book | 1.22 |
| Dividend yield | 0.00% |
| Market cap | 2.57B |
| Analyst consensus | Buy (8 buy / 5 hold / 3 sell) |
| Avg price target | 12.25 USD |
Related research pages
Frequently asked questions
When is NuScale Power (SMR)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for SMR. This page updates as the calendar is published.
Did SMR beat earnings last quarter?
In its 2026-05-07 report, SMR posted EPS of -0.14 USD versus a -0.11 USD estimate — a miss of 27.3%.
What is SMR's earnings track record?
Over the last 6 reported quarters with consensus data, SMR beat estimates 2 times (33%).
What is SMR's current P/E ratio and EPS?
SMR trades at a trailing P/E of -3.60 on trailing EPS of -2.356318682457975 USD.
What do analysts rate SMR?
Analyst consensus is "Buy" across 16 ratings (0 strong buy, 8 buy, 5 hold, 3 sell, 0 strong sell). Average 12-month price target: 12.25 USD.